rituximab combined chemotherapy

2 trials

Sponsors

Koh Katsuyoshi, Japan Adult Leukemia Study Group

Conditions

Burkitt leukemiamature B-cell lymphoma mature B-cell lymphoma

Phase 2

Phase II study of multi-agent chemotherapy in patients with adult Burkitt leukemia.

Active, not recruitingJPRN-UMIN000010641

Japan Adult Leukemia Study GroupBurkitt leukemia

Start: 2013-07-07Target: 21Updated: 2026-06-29

Multicenter clinical trial to evaluate the efficacy of rituximab combination chemotherapy for children or AYAswith localized mature B-cell lymphoma

RecruitingJPRN-jRCTs041210104

Koh Katsuyoshimature B-cell lymphoma mature B-cell lymphoma

Start: 2021-12-27Target: 100Updated: 2026-06-29

Related Papers

Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma: protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children’s Cancer Group Multicentre Trial, JPLSG B-NHL-20)

BMJ Open2024-03-014 citations